Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Pain × Ralfinamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 1 Neuroma 1

Interventions

Fentanyl 7 Zoledronic Acid 6 Radiotherapy 6 Morphine 6 Ibandronic Acid 6 nabiximols 5 Ketamine 5 Hydromorphone 5 Analgesia 5 Tapentadol 4 Oxycodone 4 Acetaminophen 4 alvimopan 3 Ropivacaine 3 Prednisone 3 Lidocaine 3 Acupuncture Therapy 3 cabozantinib 2 Tetrodotoxin 2 Mitoxantrone 2 Gabapentin 2 Docetaxel 2 resiniferatoxin 1 oxycodone-acetaminophen 1 oxycodone naloxone combination 1 ixabepilone 1 Triamcinolone Acetonide 1 Triamcinolone 1 Therapeutics 1 Taxes 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01019824 2017-09-15

Efficacy and Safety of Ralfinamide in Patients With Chronic Neuropathic Low Back Pain

Newron Pharmaceuticals SPA

Phase 3 Completed

Neuroma, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡